FIELD: medicine.
SUBSTANCE: invention refers to biology and medicine, and can be used in clinical practice for therapy of diseases related to lipid storage disease and disorders of lipoprotein metabolism. What is presented is a sorbent for removal lipoproteins (LDLP) from human plasma and blood, which contains a non-woven microfiber matrix of polypropylene and polyacrylic acid covalently bond to a matrix surface. The sorbent is produced by photo-induced graft polymerisation of acrylic acid on the surface of the sorbent matrix. The sorbent matrix is processed with a photoinitiator solution in a volatile solvent and air-dried. The sorbent matrix is then immersed into an aqueous solution of acrylic acid, removed from a solution of acrylic acid, laid on a flat substrate, coated with an ultraviolet-transparent plate from above and exposed to ultraviolet through this plate. The produced sorbent has the high sorptive capacity and LDLP selectivity.
EFFECT: method is easy to implement and cost-effective.
2 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING SURFACE-GRAFTED POLYMER ON SURFACE OF POLYMER FILM | 2011 |
|
RU2487146C1 |
METHOD OF OBTAINING SORBENT BASED ON INORGANIC POROUS GRANULES AND POLYHYDROXYFULLERENE FOR REMOVING ATHEROGENIC LIPOPROTEIN FROM BLOOD PLASMA | 2012 |
|
RU2484812C1 |
SORPTION MATERIAL, METHOD OF ITS PRODUCTION AND METHOD OF ITS APPLICATION | 2016 |
|
RU2641924C1 |
ANTISEPTIC SORPTION MATERIAL, METHOD FOR MAKING IT AND BASED WOUND HEALING DRESSING | 2013 |
|
RU2546014C2 |
SORBENT FOR COMBINED REMOVAL FROM HUMAN PLASMA OF ATHEROGENIC LIPOPROTEIDS AND C-REACTIVE PROTEIN | 2019 |
|
RU2700605C1 |
SORBENT FOR ANTIBODY REMOVAL FROM WHOLE BLOOD AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2360707C1 |
ADSORBENT FOR EXTRACTING ATHEROGENIC LIPOPROTEINS FROM BIOLOGICAL LIQUIDS | 1992 |
|
RU2029564C1 |
PEPTIDE OF APO-B RECEPTOR RESPONSIBLE FOR BINDING LOW DENSITY LIPOPROTEIN | 1994 |
|
RU2043116C1 |
ADSORBENTS FOR EXTRACTING ATHEROGENIC LIPOPROTEINS FROM BIOLOGICAL LIQUIDS | 1992 |
|
RU2029565C1 |
MAGNETICALLY CONTROLLED SORBENT AGENT FOR BILIRUBIN ELIMINATION FROM BIOLOGICAL FLUIDS | 2012 |
|
RU2524620C2 |
Authors
Dates
2015-07-27—Published
2014-05-20—Filed